Show simple item record

A first-in-human phase I/II trial of SRA737 (a Chk1 Inhibitor) in subjects with advanced cancer

dc.contributor.authorPlummer, ER
dc.contributor.authorKristeleit, RS
dc.contributor.authorCojocaru, E
dc.contributor.authorHaris, NM
dc.contributor.authorCarter, Louise
dc.contributor.authorJones, RH
dc.contributor.authorBlagden, SP
dc.contributor.authorEvans, TRJ
dc.contributor.authorArkenau, HT
dc.contributor.authorSarker, D
dc.contributor.authorDanson, S
dc.contributor.authorSymeonides, SN
dc.contributor.authorWalter, H
dc.contributor.authorOcen, J
dc.contributor.authorRandhawa, M
dc.contributor.authorKowalski, MM
dc.contributor.authorVerdon, I
dc.contributor.authorDye, A
dc.contributor.authorBanerji, U
dc.date.accessioned2019-11-19T16:01:07Z
dc.date.available2019-11-19T16:01:07Z
dc.date.issued2019en
dc.identifier.citationPlummer ER, Kristeleit RS, Cojocaru E, Haris NM, Carter L, Jones RH, et al. A first-in-human phase I/II trial of SRA737 (a Chk1 Inhibitor) in subjects with advanced cancer. J Clin Oncol. 2019;37(15_suppl):3094-.en
dc.identifier.doi10.1200/JCO.2019.37.15_suppl.3094en
dc.identifier.urihttp://hdl.handle.net/10541/622463
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/ 10.1200/JCO.2019.37.15_suppl.3094en
dc.titleA first-in-human phase I/II trial of SRA737 (a Chk1 Inhibitor) in subjects with advanced canceren
dc.typeMeetings and Proceedingsen
dc.contributor.departmentNorthern Centre for Cancer Care, Newcastle-upon-Tyneen
dc.identifier.journalJournal of Clinical Oncologyen


This item appears in the following Collection(s)

Show simple item record